Compare · DFTX vs NAII
DFTX vs NAII
Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and Natural Alternatives International Inc. (NAII): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DFTX and NAII operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- DFTX is the larger of the two at $5.20B, about 431.4x NAII ($12.0M).
- DFTX has hit the wire 14 times in the past 4 weeks while NAII has been quiet.
- DFTX has more recent analyst coverage (7 ratings vs 0 for NAII).
- Company
- Definium Therapeutics Inc.
- Natural Alternatives International Inc.
- Price
- -
- -
- Market cap
- $5.20B
- $12.0M
- 1M return
- -16.11%
- -
- 1Y return
- +306.02%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 14
- 0
- Recent ratings
- 7
- 0
Natural Alternatives International Inc.
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Latest DFTX
- Chief Executive Officer Barrow Robert was granted 750,000 shares, increasing direct ownership by 50% to 2,244,640 units (SEC Form 4)
- Chief Legal Officer Sullivan Mark was granted 125,000 shares, increasing direct ownership by 33% to 508,279 units (SEC Form 4)
- Chief Financial Officer Roberts Brandi was granted 125,000 shares, increasing direct ownership by 46% to 397,905 units (SEC Form 4)
- Chief Commercial Officer Wiley Matthew T. was granted 125,000 shares, increasing direct ownership by 53% to 362,133 units (SEC Form 4)
- Chief Medical Officer Karlin Daniel was granted 200,000 shares, increasing direct ownership by 33% to 803,699 units (SEC Form 4)
- Definium Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder
- Definium Therapeutics Announces New Employee Inducement Grants
- Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026
- Definium Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
Latest NAII
- SEC Form S-8 filed by Natural Alternatives International Inc.
- SEC Form 10-Q filed by Natural Alternatives International Inc.
- SEC Form NT 10-Q filed by Natural Alternatives International Inc.
- CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition
- Natural Alternatives International Inc. filed SEC Form 8-K: Leadership Update
- CarnoSyn® Brands Launches CarnoSyn® 4X, a Next-Generation Beta-Alanine for Sports Performance
- Natural Alternatives International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 4 filed by Natural Alternatives International Inc.
- SEC Form 4 filed by Natural Alternatives International Inc.
- President, COO, & Sec. Wolf Kenneth covered exercise/tax liability with 5,151 shares and was granted 15,000 shares, increasing direct ownership by 7% to 141,831 units (SEC Form 4)